BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7080897)

  • 1. Biochemical effects of nomifensine on catecholaminergic systems: in vivo studies.
    Algeri S; Ponzio F; Achilli G; Perego C
    Adv Biochem Psychopharmacol; 1982; 31():219-28. PubMed ID: 7080897
    [No Abstract]   [Full Text] [Related]  

  • 2. Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d-amphetamine, methylphenidate and nomifensine.
    Algeri S; Brunello N; Vantini G
    Pharmacol Res Commun; 1980 Jul; 12(7):675-81. PubMed ID: 6105682
    [No Abstract]   [Full Text] [Related]  

  • 3. Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine.
    Keller HH; Schaffner R; Carruba MO; Burkard WP; Pieri M; Bonetti EP; Scherschlicht R; Da Prada M; Haefely WE
    Adv Biochem Psychopharmacol; 1982; 31():249-63. PubMed ID: 6979165
    [No Abstract]   [Full Text] [Related]  

  • 4. Place preference conditioning with methylphenidate and nomifensine.
    Martin-Iverson MT; Ortmann R; Fibiger HC
    Brain Res; 1985 Apr; 332(1):59-67. PubMed ID: 3922561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomifensine and central monoamine neurons: histofluorescence studies.
    Smialowska M
    Pol J Pharmacol Pharm; 1977; 29(5):509-19. PubMed ID: 145591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nomifensine and body temperature of the rat: interaction with reserpine, chlorpromazine and amphetamine].
    Puche E; Mundo A; García Morillas M; Baeyens JM; Bolaños J
    Arch Farmacol Toxicol; 1979 Aug; 5(2):123-32. PubMed ID: 533317
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopaminergic properties of nomifensine.
    Gianutsos G; Morrow G; Light S; Sweeney MJ
    Pharmacol Biochem Behav; 1982 Nov; 17(5):951-4. PubMed ID: 6294689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct effect of a nomifensine derivative on dopamine receptors.
    Poat JA; Woodruff GN; Watling KJ
    J Pharm Pharmacol; 1978 Aug; 30(8):495-7. PubMed ID: 28397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute effects of nomifensine on brain levels of NE and DA in rats].
    Ravizza L; Torre E; Bogetto F; Rebaudengo P
    Minerva Psichiatr; 1980; 21(1):45-7. PubMed ID: 7464482
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for central selective dopamine receptor stimulation in the mediation of nomifensine-induced hyperalgesia and the effects of opiate antagonists.
    Gonzalez JP; Sewell RD; Spencer PS
    Neuropharmacology; 1981 Nov; 20(11):1039-45. PubMed ID: 6275288
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on brain metabolism of biogenic amines.
    Schacht U; Leven M; Bäcker G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):77S-87S. PubMed ID: 199222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of benztropine and nomifensine on dopamine and noradrenaline terminals in rat brain.
    Broch OJ
    Eur J Pharmacol; 1979 Oct; 58(4):419-24. PubMed ID: 510376
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereoselective inhibition of synaptosomal catecholamine uptake by nomifensine.
    Schacht U; Leven M
    Eur J Pharmacol; 1984 Feb; 98(2):275-7. PubMed ID: 6714310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate restores ventral tegmental area dopamine neuron activity in prenatal ethanol-exposed rats by augmenting dopamine neurotransmission.
    Choong KC; Shen RY
    J Pharmacol Exp Ther; 2004 May; 309(2):444-51. PubMed ID: 14724217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats.
    Samanin R; Bernasconi S; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):377-80. PubMed ID: 1234558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphological restructurings in the brain due to a decrease in the catecholamine level].
    Otellin VA; Kucherenko RP; Gilerovich EG; Usova IP; Fedosikhina LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):978-81. PubMed ID: 6089476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic involvement in the hyperalgesic effect of nomifensine.
    Gonzalez JP; Sewell RD; Spencer PS
    Life Sci; 1981 Feb; 28(8):951-6. PubMed ID: 7219061
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cerebral NE and DA levels after chronic treatment with nomifensine].
    Ravizza L; Bogetto F; Torre E; Rebaudengo P
    Minerva Psichiatr; 1980; 21(1):55-6. PubMed ID: 7464484
    [No Abstract]   [Full Text] [Related]  

  • 19. Uptake of [3H]dopamine into dopaminergic and noradrenergic neurones of the isolated neurointermediate lobe of the rat hypophysis. Effects of desipramine and nomifensine.
    Racké K; Muscholl E
    J Neurochem; 1983 Nov; 41(5):1488-91. PubMed ID: 6619880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of nomifensine: a review of animal studies.
    Fielding S; Szewczak MR
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):12-20. PubMed ID: 6370970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.